Showing 1 to 2 of 2 Clinical Trials
CLINICAL TRIAL Trial No ClinicalTrials.gov ID |
Principal Investigator
Coordinator |
||
---|---|---|---|
A Phase 3, Multicenter, Randomized, Double-Blind Study of MK-7684 With Pembrolizumab as a Coformulation (MK-7684A) Versus Pembrolizumab Monotherapy as First Line Treatment for Participants With PD-L1 Positive Metastatic Non-Small Cell Lung Cancer
KEYVIBE-003 (MK-7684A-003) NCT05734105 ![]() |
CENTRE UNIVERSITAIRE DE SANTE MCGILL
![]() |
Gastro-Intestinal Stromal Tumor |
Dr. Ramy Saleh Alina Lungescu 514-934-1934 |
A Phase 3 Randomized, Open-Label, Multicenter Clinical Study of CGT9486+Sunitinib vs. Sunitinib in Subjects With Locally Advanced, Unresectable, or Metastatic Gastrointestinal Stromal Tumors
Peak NCT05208047 ![]() |
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL
![]() |
Gastro-Intestinal Stromal Tumor |
Dr. Jonathan Noujaim Samara Bloom 514-252-3400 poste 6244 |